{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T09:48:23Z","timestamp":1775036903197,"version":"3.50.1"},"reference-count":0,"publisher":"American Association for Cancer Research (AACR)","issue":"4","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,1]]},"abstract":"<jats:p>In a small adjuvant trial of patients with early-stage triple-negative breast cancer, a personalized mRNA neoantigen vaccine induced robust, multitarget T-cell responses that persisted for years. Notably, the vaccine was administered on its own, without concurrent chemotherapy or checkpoint blockade, highlighting the treatment\u2019s stand-alone potential to drive durable antitumor immunity.<\/jats:p>","DOI":"10.1158\/2159-8290.cd-nw2026-0019","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T21:04:41Z","timestamp":1772226281000},"page":"OF1-OF1","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Personalized mRNA Vaccine Spurs Lasting Immunity in TNBC"],"prefix":"10.1158","volume":"16","member":"1086","published-online":{"date-parts":[[2026,2,27]]},"container-title":["Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/doi\/10.1158\/2159-8290.CD-NW2026-0019\/774918\/Personalized-mRNA-Vaccine-Spurs-Lasting-Immunity","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/16\/4\/OF1\/775535\/Personalized-mRNA-Vaccine-Spurs-Lasting-Immunity","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/16\/4\/OF1\/775535\/Personalized-mRNA-Vaccine-Spurs-Lasting-Immunity","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T07:15:09Z","timestamp":1775027709000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/16\/4\/OF1\/775535\/Personalized-mRNA-Vaccine-Spurs-Lasting-Immunity"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":0,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,2,27]]},"published-print":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2159-8290.cd-nw2026-0019","relation":{},"ISSN":["2159-8274","2159-8290"],"issn-type":[{"value":"2159-8274","type":"print"},{"value":"2159-8290","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]}}}